Microsoft Is Down ~30% From Its Peak. July 28 Is the Number That Matters.
A ~$190B capex bet, Azure at 40% growth, and a stock trading near 52-week lows heading into FY26 Q4 earnings.
Nike Is Down 45% From Its Peak. The Brand Is Still There.
The turnaround is real but slow. China is the problem nobody has solved yet.
The wrong side of the insurance trade
July 6, 2026 The Wrong Side of the Insurance Trade What Wall Street is missing while watching reinsurers fall. Sponsored…
Datadog Just Crossed $1 Billion in a Quarter. The Market Is Pricing the Wrong Story.
DDOG is up 95% year-to-date. The real question is what the August 6 report actually reveals.
SPCX joins Nasdaq-100 Monday. The float is tiny.
July 5, 2026 SpaceX Joins the Nasdaq-100 Monday Forced buying meets a float that barely exists. Sponsored First a note…
TSMC Reports July 16. The Margin Math Is More Interesting Than the Revenue Beat.
A 45% year-to-date gain and a $56 billion capex cycle have the market asking the wrong question.
GLP-1 Drugs Just Crossed 18% of U.S. Adults. The Food Industry Has Nowhere to Hide.
The real trade is not the drug makers. It is the stocks caught in the structural demand collapse.
The fine isn’t the problem
July 4, 2026 The Fine Isn’t the Problem What the Google ruling actually unlocked in Europe. Sponsored First a note…
MercadoLibre Grew Revenue 49%. The Stock Is Down 35%.
The margin selloff was real. So is the question of whether the market read it correctly.
BofA Says Three Hikes. The Market Is Only Pricing Two. Someone Is Wrong.
The gap between Wall Street’s boldest Fed call and actual market pricing is the trade of the second half.